Two Clinical Studies on the Absorption of Calcium

Albion Human Nutrition: St. Clair Shores, Michigan, December 31, 2007:
Over the course of the 2007 calendar year, two clinical studies on the absorption of calcium have demonstrated that Albion’s patented calcium ingredient, DiCalcium Malate has superior bioavailability to other popular forms of calcium. The dosage of calcium was different in each of the studies. In one study, the calcium absorption comparison was made at a high dose, 900 mg, while in the other study the dosage was a more moderate 400 mg (these were elemental levels of calcium per dose).

Applying pharmacokinetic measures, DiCalcium Malate was shown to have a higher rate of absorption and also continued the elevation of serum calcium for a longer time period. This indicates that the absorption of the calcium from DiCalcium Malate continues for a longer period of time than the common calcium form. An article covering this research is being prepared for publication; however, a preliminary report on the latest study is available from Albion’s Human Nutrition Division.

For more questions or to get the full report please contact:

Max R. Motyka
Albion Human Nutrition Director
100 Maple Park Blvd., Suite 110
St. Clair Shores, MI 48081
(801) 825-9877 or (800) 222-0733
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.